The world cheered on Monday when Pfizer Inc announced its shot was more than 90% effective based on initial trial
With tropical heat, remote island communities and a dearth of ultra-cold freezers, many Asian countries aren’t betting on Pfizer’s experimental vaccine solving their Covid-19 crisis any time soon.
The world cheered on Monday when Pfizer Inc announced its shot, jointly developed with BioNTech SE, was more than 90% effective based on initial trial results.
Yet health experts cautioned that the vaccine, should it be approved, was no silver bullet - not least because the genetic material it’s made from needs to be stored at temperature
Continue Reading on The Express Tribune
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.